Results 11 to 20 of about 593,039 (291)

Melanoma [PDF]

Journal of the National Comprehensive Cancer Network, 2012
Melanoma is a relatively common neoplasm which is increasing in incidence. Melanoma appears as a variegated irregular maculopapular lesion usually on the skin, but possibly on mucosae, conjunctiva, orbit, nails and oesophagus. They may be black, brown,
Daniel G, Coit, Robert, Andtbacka, Christopher J, Anker, Christopher K, Bichakjian, William E, Carson, Adil, Daud, Raza A, Dilawari, Dominick, Dimaio, Valerie, Guild, Allan C, Halpern, F Stephen, Hodi, Mark C, Kelley, Nikhil I, Khushalani, Ragini R, Kudchadkar, Julie R, Lange, Anne, Lind, Mary C, Martini, Anthony J, Olszanski, Scott K, Pruitt, Merrick I, Ross, Susan M, Swetter, Kenneth K, Tanabe, John A, Thompson, Vijay, Trisal, Marshall M, Urist   +24 more
openaire   +4 more sources

Melanoma [PDF]

Journal of Surgical Oncology, 2019
AbstractCurrent recommendations by the United States Preventive Services Task Force do not support screening for skin cancer. Melanoma is unique among cancers because detection is through visual inspection. Development of technologies that aid visual inspection have supported screening strategies in high‐risk populations such as older fair skinned ...
Conor H. O'Neill, Charles R. Scoggins
openaire   +4 more sources

The effect of COVID-19 emergency in the management of melanoma in Italy

Dermatology Reports, 2021
The COVID-19 pandemic has severely hampered the functioning of any health system, absorbing a considerable amount of resources and with the threat of widespread infection in the health services.
Intergruppo Melanoma Italiano
doaj   +1 more source

Association of MC1R Variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study [PDF]

, 2010
<p><b>Background</b> Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associated with a high risk for melanoma. Penetrance of CDKN2A mutations is modified by pigmentation characteristics, nevus phenotypes,
Pastorino, L., Melanoma Genetics Consortium, Goldstein, A M, Taylor JC, Ming M, Taylor Y, Martin NG, PUIG S, Rull R, Gliori S, Holland EA., Gonzalez M, Calista, D, Mackie, R.M., Lindén D, N. K. Hayward, Randerson-Moor, J, Palou J, Vilalta A, Ming, M. E., V. Höiom, Belle, P. van, Conill C, Gillanders, E, Avril, M.F., Vidal-Sicart S, Carrera, C., Bishop, J.A.N., Lang, J. M., Bishop, D. T., Mohamdi, H., GRUIS N, Bressac-de Paillerets, B, BIANCHI-SCARRÀ G, Gruis NA, P. A. Kanetsky, Bressac-de Paillerets, B., Malvehy J, N. Gruis, Whiteman DC, CARRERA C, Hayward, N. K., Tucker, M.A., G. J. Mann, van der Velden, P, Badenas C, R. M. Mackie, Stark, M., Nasti S, Marti-Laborda R, GenoMEL, Harbst K, V. Chaudru, RANDERSON-MOOR J, B. Bressac-de Paillerets, C. Ingvar, ELDER DE, PASTORINO L, J. Randerson-Moor, Tsao, H, Mohamdi, H, Landi G, Cuellar F, HAYWARD NK, AVRIL MF, Brassac-de Paillerets, B., Minghetti P, van Belle, P., Carrera, C, C. J. Njauw, Kanetsky P, E. Gillanders, A. M. Goldstein, Calista, D., Hayward, N K, Gargiulo S, W. BRUNO, Kanetsky, P.A., Arguís P, Bianchi-Scarra, G., L. Pastorino, D. E. Elder, Bertazzi PA, BERGMAN W, Chaudru, V, Mackie, R M, HÖIOM V, Battistuzzi L, Duffy DL, Origone P, Elder, D. E., Holland, E.A., HANSSON J, MacGregor S, MANN GJ, TUCKER MA, Mack T, Lang, J.M., F. Demenais, X. R. Yang, Ancero A, de Lichy M, Newton Bishop, J. A., Bianhi-Scarrà G, Landi, MT, Leake S, Mann, G J, Landi, M.T., VAN BELLE P, Stark, M, Hayward, N.K., van Mourik L, Yang, X.R., Parossian S, Demenais, F, Nielsen K, Elder, D.E., Tsao, H., Arcangeli F, Montgomery GW, MOHAMDI H, CHAUDRU V, J. Palmer, Mackie, R., M. E. Ming, Demenais, F., AZIZI E, Ming, M E, M. T. Landi, Azizi, E., Holland, E A, Randerson-Moor, J., Alós L, Gruis, N, Olsson, Håkan, J. M. Lang, van Nieuwpport FA, Castel T, LANDI MT, LANG JM, M. F. Avril, Haynes S, Kanetsky, P. A., Queirolo P, Karpavicius B, BISHOP DT, Palmer, J., M. Harland, Hogg, D., J. Hansson, CALISTA D, VAN DER VELDEN P, van der Velden, P., Yang, X R, Chaudru, V., Bergman, W., van Belle, P, Chan M, Höiom, V, BRUNO W, Kanetsky, P A, PALMER J, NJAUW CJ, Lang, J., H. Tsao, Sánchez M, G. Bianchi-Scarrà, Vilella R, NEWTON BISHOP JA, Avril, M F, Maubec E, Goldstein, A.M., P. van der Velden, J. A. Newton Bishop, KANETSKY PA, Mila M, Hoiom, V., Melanoma Genetics Consortium: Demenais F, H. Olsson, BRESSAC-DE PAILLERETS B, Harland, M, Tuominen R, E. A. Holland, Affleck P, Whittaker L, Loo JC, Mackie, R. M., Tesema L, Njauw, C. J., Iles MM, Borg Å, Holland, E. A., Ingvar, Christian, MACKIE RM, Hansson, J., HOLLAND EA, GHIORZO P, Butille JA, Cervera R, Ogbah Z, Azizi, E, Bishop, D.T., C. Carrera, Velden, P. van der, Landi, M. T., Campo A, Ming, M.E., Newton Bishop, J A, Jeannin P, Lang, J M, Bishop, D T, MING ME, Njauw, C J, E. Azizi, HARLAND M, Lang J, M. A. Tucker, Elder D, Gabriel D, Gruis, N., Gillanders, E., W. Bergman, Lesueur F, Capirossi D, DEMENAIS F, STARK M, Mackie R, Ingvar, C., GILLANDERS E, Njauw, C.J., P. van Belle, Barrett JH, GOLDSTEIN AM, M. Stark, Hogg, D, Iglesias P, Puig, S., D. Hogg, Elder, D E, INGVAR C, Kukalizch K, Mann, G.J., Olsson, H., Bergman, W, Pastorino, L, Mann, G. J., S. Puig, Schmid H, Tucker, M A, D. Calista, Mitra N, TSAO H, YANG XR, Kefford RF, P. GHIORZO, Njauw CN, Avril, M. F., Jönsson G, Harrison J, HOGG D, Ruffin A, Aguilera P, D. T. Bishop, Corda E, OLSSON H, Puig, S, Hansson, J, Palmer, J, Bianchi-Scarrà, G, H. Mohamdi, Måsbäck A, Newton Bishop, J.A., Harland, M., Goldstein, A. M., Olsson, Håkan,, Bishop, DT, Ingvar, Christian,, Hayward, NK, Bishop, JAN, Lund University., Goldstein, AM, Kanetsky, PA, Elder, DE   +282 more
core   +1 more source

TP63 is implicated in apoptotic dysregulation in melanoma [PDF]

, 2010
PhDCutaneous melanoma is an aggressive malignancy accounting for 4% of skin cancers but 80% of all skin-cancer related deaths. Its incidence is rapidly rising and advanced disease is notoriously treatment-resistant.
Matin, Rubeta N H
core   +2 more sources

PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cells [PDF]

, 2011
PAX transcription factors play an important role during development and carcinogenesis. In this study, we investigated PAX2 protein levels in melanocytes and melanoma cells by Western Blot and immunofluorescence analysis and characterized the role of ...
Ungerer Christopher, Hardt, Katja, Kai Doberstein, Hardt Katja, Pfeilschifter, Josef (Prof. Dr.), Lee Sophia Boyoung, Mihic-Probst Daniela, Mihic-Probst, D, Ungerer, Christopher, Mittelbronn, Michel, Mittelbronn, Michel Guy André, Bürger Claudia, Gutwein, P, Gutwein, Paul, Wolf-Henning Boehncke, Wieland, A, Sophia Boyoung Lee, Pfeilschifter, J, Josef Pfeilschifter, Baumgarten Peter, Paul Gutwein, Hardt, K, Pfeilschifter, Josef M., Michel Mittelbronn, Lee, Sophia Boyoung, Daniela Mihic-Probst, Claudia Bürger, Anja Wieland, Gutwein Paul, Wieland Anja, Baumgarten, Peter, Katja Hardt, Doberstein, K, Lee, S B, Peter Baumgarten, Baumgarten, P, Doberstein Kai, Mittelbronn Michel, Boehncke, Wolf-Henning, Ungerer, C, Doberstein, Kai, Boehncke Wolf-Henning, Wieland, Anja, Boehncke, W H, Bürger, Claudia, Bürger, C, Christopher Ungerer, Mittelbronn, M, Mihic-Probst, Daniela, Pfeilschifter Josef, Pfeilschifter, Josef   +50 more
core   +2 more sources

Proton beam radiotherapy in the management of uveal melanoma: clinical experience in Scotland [PDF]

, 2008
<p>Aim: To evaluate proton-beam radiotherapy (PBRT) in the management of uveal melanoma in Scotland.</p> <p>Methods: A retrospective review was undertaken on all patients receiving PBRT for uveal melanoma (1994–2005).
McConnachie, A., Alex Taylor, Alex Kacperek, Aziz, S., Samir Aziz, Kemp, E., Andrzej McConnachie, Ewan Kemp, Kacperek, A., Taylor, A.   +9 more
core   +1 more source

Measles virus causes immunogenic cell death in human melanoma [PDF]

, 2011
NoOncolytic viruses (OV) are promising treatments for cancer, with several currently undergoing testing in randomised clinical trials. Measles virus (MV) has not yet been tested in models of human melanoma.
Russell, S, Selby, P., Hadac, E., Donnelly, Oliver G, Jennings, V., Errington-Mais, F., Melcher, Alan A, Hadac, Elizabeth, Bond, J, Melcher, A.A., Bond, Jacquelyn, Selby, P, Bond, J., Peach, H., Vile, Richard, Steele, L., Vile, R., Hadac, E, Donnelly, O.G., Russell, Stephen, Harrington, K.J., Harrington, K, Peach, Howard, Steele, Lynette, Melcher, AA, Errington-Mais, Fiona, Harrington, Kevin, Russell, S., Phillips, Roger M., Pandha, H.S., Selby, Peter, Errington-Mais, F, Jennings, V, Scott, K, Phillips, RM, Phillips, Roger M, Scott, K., Pandha, Hardev, Vile, R, Jennings, Victoria, Steele, L, Pandha, H, Scott, Karen, Donnelly, OG, Peach, H   +44 more
core   +1 more source

The State of Melanoma: Emergent Challenges and Opportunities [PDF]

, 2021
Five years ago, the Melanoma Research Foundation (MRF) conducted an assessment of the challenges and opportunities facing the melanoma research community and patients with melanoma.
Soengas, Maria S, Johnson, Douglas B, Swetter, Susan M, Fox, Bernard A, Atkins, Michael B, Jeter, Joanne M, Ferris, Laura K, Nelson, Kelly C, Hernando, Eva, Kirkwood, John M, Leachman, Sancy A, Aguirre-Ghiso, Julio A, Mays, Darren, Hanks, Brent A, Flaherty, Keith T, Chandra, Sunandana, Foundation, on behalf of the Melanoma Research, Sosman, Jeffrey A, Herlyn, Meenhard, Sullivan, Ryan J, Sondak, Vernon K, Merlino, Glenn, Cassidy, Pamela B, Pavlick, Anna C, Gershenwald, Jeffrey E, Chapman, Paul B, Tsao, Hensin, Eroglu, Zeynep, Grossman, Douglas, Gerhsenwald, Jeffrey E, Gibney, Geoffrey T, Hanniford, Douglas, Curiel-Lewandrowski, Clara, Fisher, David E, Weeraratna, Ashani T, Tawbi, Hussein A, Daud, Adil, Khleif, Samir N, Soengas, MS, Paul B. Chapman, Samir N. Khleif, Clara Curiel-Lewandrowski, Sancy A. Leachman, Laura K. Ferris, Kelly C. Nelson, Jeffrey E. Gershenwald, Eva Hernando, Ashani T. Weeraratna, Douglas B. Johnson, Hensin Tsao, Ryan J. Sullivan, Michael B. Atkins, Jeffrey A. Sosman, Anna C. Pavlick, Douglas Hanniford, Maria S. Soengas, Sunandana Chandra, Julio A. Aguirre-Ghiso, Pamela B. Cassidy, Brent A. Hanks, John M. Kirkwood, Adil Daud, Meenhard Herlyn, Hussein A. Tawbi, Keith T. Flaherty, Bernard A. Fox, David E. Fisher, Glenn Merlino, Joanne M. Jeter, Darren Mays, Zeynep Eroglu, Geoffrey T. Gibney, Vernon K. Sondak, Susan M. Swetter, Douglas Grossman   +74 more
core   +1 more source

Melanoma

Clinical Radiology, 2004
The incidence of malignant melanoma in the UK is still rising despite public health warnings about the risks of excessive sun exposure. This aggressive tumour can metastasize to virtually any organ, even years after resection of the primary lesion and cause a variety of radiological appearances.
E, Kalkman, G, Baxter
openaire   +4 more sources